Published in Acta Virol on July 01, 1975
Variability of variola and alastrim virus. J Hyg Epidemiol Microbiol Immunol (1967) 1.17
Correlation between TS phenotype and pathogenicity of some animal viruses. Arch Gesamte Virusforsch (1973) 1.11
Morphological characterisitcs of the pathological process in the central nervous system of monkeys infected with variants of measles virus strain L-16. Acta Virol (1979) 1.01
Pathomorphologic characterization of CNS damage in monkeys infected with persistent variant of measles virus vaccine strain L-16. Acta Virol (1987) 0.81
[Possible mechanism of orthopoxvirus preservation in nature]. Vopr Virusol (1979) 0.81
Further-attenuated measles vaccine: virus passages affect viral surface protein expression, immunogenicity and histopathology pattern in vivo. Res Virol (1991) 0.81
Genetic evidence for variant selection in the course of dilute passaging of mumps vaccine virus. Res Virol (1992) 0.81
Comparative study on the neurovirulence of different vaccine strains of parotitis virus in monkeys. Acta Virol (1985) 0.79
[A study of the genetic marker M of vaccinia virus variants]. Vopr Virusol (1969) 0.79
On the "neuropathogenicity" mechanism of vaccinia virus. Acta Virol (1973) 0.78
Reproduction of human and animal influenza viruses in human nasal polyp organ cultures. Acta Virol (1985) 0.78
Mumps virus variants in heterogeneous mumps vaccine. Lancet (1993) 0.78
Effect of immunosuppression on morphological changes in CNS of monkeys infected with different measles virus vaccine strains. Acta Virol (1984) 0.77
[Results of a study of live mumps vaccine from strain L-3 produced by the Moscow research institute for viral preparations. Characteristics of the vaccine]. Vopr Virusol (1977) 0.76
Study of mumps virus invasiveness in monkeys. Acta Virol (1984) 0.76
Laboratory markers for over-attenuation of mumps vaccine virus. Vaccine (1988) 0.75
[Morphologic criteria of tumorogenicity of various cell cultures in heterotransplant experiments with hamsters]. Vopr Virusol (1969) 0.75
[Further study of the pathological process induced in monkeys by LPV oncornavirus]. Vopr Virusol (1976) 0.75
[The central press in the propaganda of medical and health knowledge (1921-1932)]. Sov Zdravookhr (1983) 0.75
[Sanitary education and the problems of improving work conditions during the first few years of the Five-Year Plan]. Gig Sanit (1985) 0.75
[Comparative study of the sensitivity of the serological methods used in detecting mumps virus antibodies]. Vopr Virusol (1987) 0.75
[Laboratory diagnosis of enteric helminthiasis (review of the literature)]. Klin Lab Diagn (1994) 0.75
[Preparation and characteristics of diploid cell strains from the tissues of a bovine embryo]. Vopr Virusol (1979) 0.75
[Immunofluorescence reaction in studying humoral immunity in parotitis]. Vopr Virusol (1985) 0.75
[Development and practical use of new experimental models of the various forms of herpetic infection]. Vopr Virusol (1986) 0.75
[Various biological properties of diploid cell strains derived from various tissues of human embryo]. Vopr Virusol (1977) 0.75
Freeing rabies virus of the neuroallergenic factor from brain tissue. Acta Virol (1981) 0.75
[Experimental basis for smallpox chemoprophylaxis]. Biull Eksp Biol Med (1966) 0.75
[Detection of mumps virus antibody by macro- and micro-hemagglutination inhibition tests]. Vopr Virusol (1975) 0.75
Morphological characteristics of the infection of animals with tick-borne encephalitis virus persisting for a long time in cell cultures. Acta Virol (1978) 0.75
[The agglutination of erythrocytes treated with trypsin with rubella virus antigen]. Vopr Virusol (1973) 0.75
[Experimental measles infection in rodents]. Vopr Virusol (1990) 0.75
[Study of the correlation between neutralization tests and hemagglutination inhibition tests in determinations of mumps virus antibodies]. Vopr Virusol (1975) 0.75
[Smallpox vaccination with protection by interferon and an interferon inducer]. Vopr Virusol (1980) 0.75
On the prophylactic activity on N-methyl isatin beta-thiosemicarbazone against smallpox infection. Acta Virol (1967) 0.75
[A study of the mutability of tick-borne encephalitis virus. 4. Pathogenic properties of various strains of the tick-borne encephalitis group and their variants]. Vopr Virusol (1969) 0.75
Morphological criteria of neurovirulence of viruses in viral vaccine production. Acta Virol (1971) 0.75
[Study of the lymphocytosis-stimulating factor of Bordetella pertussis]. Biull Eksp Biol Med (1972) 0.75
[A trial of the use of bifikol and lactic bifidobacterin for treating children with enterobiasis]. Med Parazitol (Mosk) (1994) 0.75
[Persistence of the measles antigen in the central nervous system of monkeys infected with clonal variants of the L-16 vaccinal strain of the measles virus]. Vopr Virusol (1983) 0.75
[Teratogenic properties of freshly isolated strains of rubella virus in experiments on animals]. Vopr Virusol (1977) 0.75
Experimental-scale measles and mumps vaccine production on microcarrier-grown cells. Vaccine (1989) 0.75
[Induction by the oncornavirus LPV of a systemic pathological process in monkey hematopoietic organs]. Vopr Virusol (1974) 0.75
[Detection of cell culture tumorigenic activity by heterotransplantation into hamster cheek pouch tissue using immunodepressants]. Vopr Virusol (1976) 0.75
[Comparative clinico-morphological research on measles and mumps infections in an experiment on guinea pigs]. Vopr Virusol (1988) 0.75
[Induction of resistance in hamsters to heterotransplantation of cells transformed by the blood of a hemocytoblastosis patient]. Vopr Virusol (1972) 0.75
[Prevention of mumps]. Feldsher Akush (1983) 0.75
[Results of studying a live mumps vaccine from strain L-3 manufactured by the Moscow Research Institute of Viral Preparations. The reactogenic and antigenic properties of the vaccine]. Vopr Virusol (1977) 0.75